|
PTPRA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.595900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.060350E-01 |
| Normal-vs-Stage2 |
1.931220E-01 |
| Normal-vs-Stage3 |
1.833540E-02 |
| Normal-vs-Stage4 |
1.557660E-02 |
| Stage1-vs-Stage2 |
9.897000E-01 |
| Stage1-vs-Stage3 |
2.673200E-01 |
| Stage1-vs-Stage4 |
2.766400E-01 |
| Stage2-vs-Stage3 |
4.419600E-01 |
| Stage2-vs-Stage4 |
3.714400E-01 |
| Stage3-vs-Stage4 |
8.187000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.644000E-02 |
| Normal-vs-AfricanAmerican |
7.126200E-01 |
| Normal-vs-Asian |
3.774400E-01 |
| Caucasian-vs-AfricanAmerican |
4.499800E-02 |
| Caucasian-vs-Asian |
2.830600E-01 |
| AfricanAmerican-vs-Asian |
3.106000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.543200E-03 |
| Normal-vs-Female |
7.226400E-02 |
| Male-vs-Female |
4.551600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.278030E-01 |
| Normal-vs-Age(41-60Yrs) |
7.766400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.831800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.082140E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.716800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.627400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.185030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.194200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.360840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.480250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.973700E-02 |
| Classical-VS-Follicular |
4.025600E-02 |
| Classical-VS-Other |
1.845410E-01 |
| Classical-VS-Normal |
2.567600E-01 |
| Tall-VS-Follicular |
5.021400E-01 |
| Tall-VS-Other |
8.256400E-01 |
| Tall-VS-Normal |
5.276700E-03 |
| Follicular-VS-Other |
5.889200E-01 |
| Follicular-VS-Normal |
2.295800E-02 |
| Other-VS-Normal |
6.380000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.734400E-02 |
| Normal-vs-N1 |
9.982800E-04 |
| N0-vs-N1 |
2.902400E-02 |
|
|
